{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:38:48Z","timestamp":1789094328540,"version":"build-2803163510"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA224306, R01CA231925"],"award-info":[{"award-number":["R01CA224306, R01CA231925"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA224306, R01CA231925"],"award-info":[{"award-number":["R01CA224306, R01CA231925"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT94252310452, W81XWH-22-1-0913"],"award-info":[{"award-number":["HT94252310452, W81XWH-22-1-0913"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10555-023-10153-8","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T23:01:32Z","timestamp":1699657292000},"page":"409-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies"],"prefix":"10.1007","volume":"43","author":[{"given":"Shashi","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwar Somesh","family":"Vikramdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarabjeet Kour","family":"Sudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amod","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijan","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Aslam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"10153_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1534\/genetics.104.034132","volume":"169","author":"CJ Davidson","year":"2005","unstructured":"Davidson, C. J., Tirouvanziam, R., Herzenberg, L. A., & Lipsick, J. S. (2005). Functional evolution of the vertebrate Myb gene family: B-Myb, but neither A-Myb nor c-Myb, complements Drosophila Myb in hemocytes. Genetics, 169, 215\u2013229. https:\/\/doi.org\/10.1534\/genetics.104.034132","journal-title":"Genetics"},{"key":"10153_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41389-021-00309-y","volume":"10","author":"Y Ciciro","year":"2021","unstructured":"Ciciro, Y., & Sala, A. (2021). MYB oncoproteins: emerging players and potential therapeutic targets in human cancer. Oncogenesis, 10, 19. https:\/\/doi.org\/10.1038\/s41389-021-00309-y","journal-title":"Oncogenesis"},{"key":"10153_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0092-8674(82)90138-6","volume":"31","author":"KH Klempnauer","year":"1982","unstructured":"Klempnauer, K. H., Gonda, T. J., & Bishop, J. M. (1982). Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: The architecture of a transduced oncogene. Cell, 31, 453\u2013463. https:\/\/doi.org\/10.1016\/0092-8674(82)90138-6","journal-title":"Cell"},{"key":"10153_CR4","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1073\/pnas.80.10.2834","volume":"80","author":"WJ Boyle","year":"1983","unstructured":"Boyle, W. J., Lipsick, J. S., Reddy, E. P., & Baluda, M. A. (1983). Identification of the leukemogenic protein of avian myeloblastosis virus and of its normal cellular homologue. Proceedings of the National Academy of Science U S A, 80, 2834\u20132838. https:\/\/doi.org\/10.1073\/pnas.80.10.2834","journal-title":"Proceedings of the National Academy of Science U S A"},{"key":"10153_CR5","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1038\/sj.onc.1202839","volume":"18","author":"IH Oh","year":"1999","unstructured":"Oh, I. H., & Reddy, E. P. (1999). The myb gene family in cell growth, differentiation and apoptosis. Oncogene, 18, 3017\u201333. https:\/\/doi.org\/10.1038\/sj.onc.1202839","journal-title":"Oncogene"},{"key":"10153_CR6","doi-asserted-by":"publisher","first-page":"11075","DOI":"10.1093\/nar\/16.23.11075","volume":"16","author":"N Nomura","year":"1988","unstructured":"Nomura, N., Takahashi, M., Matsui, M., Ishii, S., Date, T., Sasamoto, S., et al. (1988). Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acids Research, 16, 11075\u201311089. https:\/\/doi.org\/10.1093\/nar\/16.23.11075","journal-title":"Nucleic Acids Research"},{"key":"10153_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrc2439","volume":"8","author":"RG Ramsay","year":"2008","unstructured":"Ramsay, R. G., & Gonda, T. J. (2008). MYB function in normal and cancer cells. Nature Reviews Cancer, 8, 523\u2013534. https:\/\/doi.org\/10.1038\/nrc2439","journal-title":"Nature Reviews Cancer"},{"key":"10153_CR8","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1002\/j.1460-2075.1994.tb06945.x","volume":"13","author":"K Trauth","year":"1994","unstructured":"Trauth, K., Mutschler, B., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., & Klempnauer, K. H. (1994). Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. The EMBO Journal, 13, 5994\u20136005. https:\/\/doi.org\/10.1002\/j.1460-2075.1994.tb06945.x","journal-title":"The EMBO Journal"},{"key":"10153_CR9","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1128\/MCB.23.18.6631-6645.2003","volume":"23","author":"A Kumar","year":"2003","unstructured":"Kumar, A., Baker, S. J., Lee, C. M., & Reddy, E. P. (2003). Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb. Molecular and Cellular Biology, 23, 6631\u201345. https:\/\/doi.org\/10.1128\/MCB.23.18.6631-6645.2003","journal-title":"Molecular and Cellular Biology"},{"key":"10153_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-15-0859","volume":"6","author":"KJ Brayer","year":"2016","unstructured":"Brayer, K. J., Frerich, C. A., Kang, H., & Ness, S. A. (2016). Recurrent fusions in MYB and MYBL1 define a common, transcription factor-driven oncogenic pathway in salivary gland adenoid cystic carcinoma. Cancer Discovery, 6, 176\u2013187. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0859","journal-title":"Cancer Discovery"},{"key":"10153_CR11","doi-asserted-by":"publisher","first-page":"1150976","DOI":"10.3389\/fgene.2023.1150976","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen, X., Feng, J., Zhang, Y., Liu, J., Zhang, L., Zeng, P., et al. (2023). MYBL2 alternative splicing-related genetic variants reduce the risk of triple-negative breast cancer in the Chinese population. Frontiers in Genetics, 14, 1150976. https:\/\/doi.org\/10.3389\/fgene.2023.1150976","journal-title":"Frontiers in Genetics"},{"key":"10153_CR12","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1128\/MCB.01870-07","volume":"28","author":"JP O'Rourke","year":"2008","unstructured":"O\u2019Rourke, J. P., & Ness, S. A. (2008). Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities. Molecular and Cellular Biology, 28, 2091\u20132101. https:\/\/doi.org\/10.1128\/MCB.01870-07","journal-title":"Molecular and Cellular Biology"},{"key":"10153_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nsb0296-178","volume":"3","author":"K Ogata","year":"1996","unstructured":"Ogata, K., Kanei-Ishii, C., Sasaki, M., Hatanaka, H., Nagadoi, A., Enari, M., et al. (1996). The cavity in the hydrophobic core of Myb DNA-binding domain is reserved for DNA recognition and trans-activation. Natural Structural Biology, 3, 178\u2013187. https:\/\/doi.org\/10.1038\/nsb0296-178","journal-title":"Natural Structural Biology"},{"key":"10153_CR14","doi-asserted-by":"publisher","first-page":"6428","DOI":"10.1073\/pnas.89.14.6428","volume":"89","author":"K Ogata","year":"1992","unstructured":"Ogata, K., Hojo, H., Aimoto, S., Nakai, T., Nakamura, H., Sarai, A., et al. (1992). Solution structure of a DNA-binding unit of Myb: A helix-turn-helix-related motif with conserved tryptophans forming a hydrophobic core. Proceedings of the National Academy of Sciences U S A, 89, 6428\u20136432. https:\/\/doi.org\/10.1073\/pnas.89.14.6428","journal-title":"Proceedings of the National Academy of Sciences U S A"},{"issue":"Pt 3","key":"10153_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1042\/bj3240729","volume":"324","author":"V Facchinetti","year":"1997","unstructured":"Facchinetti, V., Loffarelli, L., Schreek, S., Oelgeschlager, M., Luscher, B., Introna, M., et al. (1997). Regulatory domains of the A-Myb transcription factor and its interaction with the CBP\/p300 adaptor molecules. Biochemical Journal, 324(Pt 3), 729\u201336. https:\/\/doi.org\/10.1042\/bj3240729","journal-title":"Biochemical Journal"},{"key":"10153_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1006\/bcmd.2001.0405","volume":"27","author":"JJ Rushton","year":"2001","unstructured":"Rushton, J. J., & Ness, S. A. (2001). The conserved DNA binding domain mediates similar regulatory interactions for A-Myb, B-Myb, and c-Myb transcription factors. Blood Cells, Molecules, and Diseases, 27, 459\u201363. https:\/\/doi.org\/10.1006\/bcmd.2001.0405","journal-title":"Blood Cells, Molecules, and Diseases"},{"key":"10153_CR17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0092-8674(94)90549-5","volume":"79","author":"K Ogata","year":"1994","unstructured":"Ogata, K., Morikawa, S., Nakamura, H., Sekikawa, A., Inoue, T., Kanai, H., et al. (1994). Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices. Cell, 79, 639\u2013648. https:\/\/doi.org\/10.1016\/0092-8674(94)90549-5","journal-title":"Cell"},{"key":"10153_CR18","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1093\/nar\/29.17.3546","volume":"29","author":"S Bergholtz","year":"2001","unstructured":"Bergholtz, S., Andersen, T. O., Andersson, K. B., Borrebaek, J., Luscher, B., & Gabrielsen, O. S. (2001). The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties. Nucleic Acids Research, 29, 3546\u20133556. https:\/\/doi.org\/10.1093\/nar\/29.17.3546","journal-title":"Nucleic Acids Research"},{"key":"10153_CR19","doi-asserted-by":"publisher","first-page":"14161","DOI":"10.1016\/S0021-9258(19)85222-5","volume":"268","author":"H Nakagoshi","year":"1993","unstructured":"Nakagoshi, H., Takemoto, Y., & Ishii, S. (1993). Functional domains of the human B-myb gene product. Journal of Biological Chemistry, 268, 14161\u201314167. https:\/\/doi.org\/10.1016\/S0021-9258(19)85222-5","journal-title":"Journal of Biological Chemistry"},{"key":"10153_CR20","first-page":"1931","volume":"8","author":"JP Sleeman","year":"1993","unstructured":"Sleeman, J. P. (1993). Xenopus A-myb is expressed during early spermatogenesis. Oncogene, 8, 1931\u20131941.","journal-title":"Oncogene"},{"key":"10153_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0092-8674(85)80018-0","volume":"41","author":"AL Katzen","year":"1985","unstructured":"Katzen, A. L., Kornberg, T. B., & Bishop, J. M. (1985). Isolation of the proto-oncogene c-myb from D. melanogaster. Cell, 41, 449\u2013456. https:\/\/doi.org\/10.1016\/S0092-8674(85)80018-0","journal-title":"Cell"},{"key":"10153_CR22","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1073\/pnas.89.7.3088","volume":"89","author":"C Kanei-Ishii","year":"1992","unstructured":"Kanei-Ishii, C., MacMillan, E. M., Nomura, T., Sarai, A., Ramsay, R. G., Aimoto, S., et al. (1992). Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proceedings National Academy Sciences U S A, 89, 3088\u20133092. https:\/\/doi.org\/10.1073\/pnas.89.7.3088","journal-title":"Proceedings National Academy Sciences U S A"},{"key":"10153_CR23","doi-asserted-by":"publisher","first-page":"21914","DOI":"10.1016\/S0021-9258(20)80628-0","volume":"268","author":"T Nomura","year":"1993","unstructured":"Nomura, T., Sakai, N., Sarai, A., Sudo, T., Kanei-Ishii, C., Ramsay, R. G., et al. (1993). Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper. Journal of Biological Chemistry, 268, 21914\u201321923. https:\/\/doi.org\/10.1016\/S0021-9258(20)80628-0","journal-title":"Journal of Biological Chemistry"},{"key":"10153_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0014-5793(94)01402-M","volume":"358","author":"T Takahashi","year":"1995","unstructured":"Takahashi, T., Nakagoshi, H., Sarai, A., Nomura, N., Yamamoto, T., & Ishii, S. (1995). Human A-myb gene encodes a transcriptional activator containing the negative regulatory domains. FEBS Letters, 358, 89\u201396. https:\/\/doi.org\/10.1016\/0014-5793(94)01402-M","journal-title":"FEBS Letters"},{"key":"10153_CR25","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.onc.1201282","volume":"15","author":"U Ziebold","year":"1997","unstructured":"Ziebold, U., & Klempnauer, K. H. (1997). Linking Myb to the cell cycle: Cyclin-dependent phosphorylation and regulation of A-Myb activity. Oncogene, 15, 1011\u20131019. https:\/\/doi.org\/10.1038\/sj.onc.1201282","journal-title":"Oncogene"},{"key":"10153_CR26","first-page":"2113","volume":"11","author":"RG Ramsay","year":"1995","unstructured":"Ramsay, R. G., Morrice, N., Van Eeden, P., Kanagasundaram, V., Nomura, T., De Blaquiere, J., et al. (1995). Regulation of c-Myb through protein phosphorylation and leucine zipper interactions. Oncogene, 11, 2113\u20132120.","journal-title":"Oncogene"},{"key":"10153_CR27","doi-asserted-by":"publisher","first-page":"102319","DOI":"10.1016\/j.jbc.2022.102319","volume":"298","author":"TU Wijeratne","year":"2022","unstructured":"Wijeratne, T. U., Guiley, K. Z., Lee, H. W., Muller, G. A., & Rubin, S. M. (2022). Cyclin-dependent kinase-mediated phosphorylation and the negative regulatory domain of transcription factor B-Myb modulate its DNA binding. Journal of Biological Chemistry, 298, 102319. https:\/\/doi.org\/10.1016\/j.jbc.2022.102319","journal-title":"Journal of Biological Chemistry"},{"key":"10153_CR28","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/sj.leu.2401113","volume":"12","author":"A Tomita","year":"1998","unstructured":"Tomita, A., Watanabe, T., Kosugi, H., Ohashi, H., Uchida, T., Kinoshita, T., et al. (1998). Truncated c-Myb expression in the human leukemia cell line TK-6. Leukemia, 12, 1422\u20131429. https:\/\/doi.org\/10.1038\/sj.leu.2401113","journal-title":"Leukemia"},{"key":"10153_CR29","first-page":"3135","volume":"57","author":"C Wallrapp","year":"1997","unstructured":"Wallrapp, C., Muller-Pillasch, F., Solinas-Toldo, S., Lichter, P., Friess, H., Buchler, M., et al. (1997). Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Research, 57, 3135\u20133139.","journal-title":"Cancer Research"},{"key":"10153_CR30","first-page":"5323","volume":"60","author":"P Kauraniemi","year":"2000","unstructured":"Kauraniemi, P., Hedenfalk, I., Persson, K., Duggan, D. J., Tanner, M., Johannsson, O., et al. (2000). MYB oncogene amplification in hereditary BRCA1 breast cancer. Cancer Research, 60, 5323\u20135328.","journal-title":"Cancer Research"},{"key":"10153_CR31","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00401-010-0763-1","volume":"120","author":"RG Tatevossian","year":"2010","unstructured":"Tatevossian, R. G., Tang, B., Dalton, J., Forshew, T., Lawson, A. R., Ma, J., et al. (2010). MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas. Acta Neuropathologica, 120, 731\u2013743. https:\/\/doi.org\/10.1007\/s00401-010-0763-1","journal-title":"Acta Neuropathologica"},{"key":"10153_CR32","doi-asserted-by":"publisher","first-page":"e0176045","DOI":"10.1371\/journal.pone.0176045","volume":"12","author":"SE Schumacher","year":"2017","unstructured":"Schumacher, S. E., Shim, B. Y., Corso, G., Ryu, M. H., Kang, Y. K., Roviello, F., et al. (2017). Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients. PLoS ONE, 12, e0176045. https:\/\/doi.org\/10.1371\/journal.pone.0176045","journal-title":"PLoS ONE"},{"key":"10153_CR33","first-page":"5271","volume":"9","author":"J Edwards","year":"2003","unstructured":"Edwards, J., Krishna, N. S., Witton, C. J., & Bartlett, J. M. (2003). Gene amplifications associated with the development of hormone-resistant prostate cancer. Clinical Cancer Research, 9, 5271\u20135281.","journal-title":"Clinical Cancer Research"},{"key":"10153_CR34","doi-asserted-by":"publisher","first-page":"42060","DOI":"10.1038\/srep42060","volume":"7","author":"G Dong","year":"2017","unstructured":"Dong, G., Mao, Q., Yu, D., Zhang, Y., Qiu, M., Dong, G., et al. (2017). Integrative analysis of copy number and transcriptional expression profiles in esophageal cancer to identify a novel driver gene for therapy. Sciences Reports, 7, 42060. https:\/\/doi.org\/10.1038\/srep42060","journal-title":"Sciences Reports"},{"key":"10153_CR35","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.1073\/pnas.130025211","volume":"110","author":"LA Ramkissoon","year":"2013","unstructured":"Ramkissoon, L. A., Horowitz, P. M., Craig, J. M., Ramkissoon, S. H., Rich, B. E., Schumacher, S. E., et al. (2013). Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proceedings National Academy Sciences U S A, 110, 8188\u20138193. https:\/\/doi.org\/10.1073\/pnas.130025211","journal-title":"Proceedings National Academy Sciences U S A"},{"key":"10153_CR36","doi-asserted-by":"publisher","first-page":"188407","DOI":"10.1016\/j.bbcan.2020.188407","volume":"1874","author":"R Bayley","year":"2020","unstructured":"Bayley, R., Ward, C., & Garcia, P. (2020). MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential. Biochimica et Biophysica Acta - Reviews on Cancer, 1874, 188407. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188407","journal-title":"Biochimica et Biophysica Acta - Reviews on Cancer"},{"key":"10153_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/CMR.0b013e3280141617","volume":"17","author":"DK Koynova","year":"2007","unstructured":"Koynova, D. K., Jordanova, E. S., Milev, A. D., Dijkman, R., Kirov, K. S., Toncheva, D. I., et al. (2007). Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma. Melanoma Research, 17, 37\u201341. https:\/\/doi.org\/10.1097\/CMR.0b013e3280141617","journal-title":"Melanoma Research"},{"key":"10153_CR38","first-page":"1833","volume":"6","author":"MM Tanner","year":"2000","unstructured":"Tanner, M. M., Grenman, S., Koul, A., Johannsson, O., Meltzer, P., Pejovic, T., et al. (2000). Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clinical Cancer Research, 6, 1833\u20131839.","journal-title":"Clinical Cancer Research"},{"key":"10153_CR39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10549-011-1600-5","volume":"130","author":"H Shi","year":"2011","unstructured":"Shi, H., Bevier, M., Johansson, R., Grzybowska, E., Chen, B., Eyfjord, J. E., et al. (2011). Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome. Breast Cancer Research and Treatment, 130, 905\u2013916. https:\/\/doi.org\/10.1007\/s10549-011-1600-5","journal-title":"Breast Cancer Research and Treatment"},{"key":"10153_CR40","doi-asserted-by":"publisher","first-page":"24206","DOI":"10.1038\/s41598-021-03624-x","volume":"11","author":"SW Lim","year":"2021","unstructured":"Lim, S. W., Tan, K. J., Azuraidi, O. M., Sathiya, M., Lim, E. C., Lai, K. S., et al. (2021). Functional and structural analysis of non-synonymous single nucleotide polymorphisms (nsSNPs) in the MYB oncoproteins associated with human cancer. Scientific Reports, 11, 24206. https:\/\/doi.org\/10.1038\/s41598-021-03624-x","journal-title":"Scientific Reports"},{"key":"10153_CR41","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.4161\/cc.9.15.12515","volume":"9","author":"G Stenman","year":"2010","unstructured":"Stenman, G., Andersson, M. K., & Andren, Y. (2010). New tricks from an old oncogene: Gene fusion and copy number alterations of MYB in human cancer. Cell Cycle, 9, 2986\u20132995. https:\/\/doi.org\/10.4161\/cc.9.15.12515","journal-title":"Cell Cycle"},{"key":"10153_CR42","doi-asserted-by":"publisher","first-page":"18740","DOI":"10.1073\/pnas.0909114106","volume":"106","author":"M Persson","year":"2009","unstructured":"Persson, M., Andren, Y., Mark, J., Horlings, H. M., Persson, F., & Stenman, G. (2009). Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proceedings National Academy Science U S A, 106, 18740\u201318744. https:\/\/doi.org\/10.1073\/pnas.0909114106","journal-title":"Proceedings National Academy Science U S A"},{"key":"10153_CR43","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1158\/1078-0432.CCR-10-0463","volume":"16","author":"Y Mitani","year":"2010","unstructured":"Mitani, Y., Li, J., Rao, P. H., Zhao, Y. J., Bell, D., Lippman, S. M., et al. (2010). Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clinical Cancer Research, 16, 4722\u20134731. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0463","journal-title":"Clinical Cancer Research"},{"key":"10153_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/ng.3500","volume":"48","author":"P Bandopadhayay","year":"2016","unstructured":"Bandopadhayay, P., Ramkissoon, L. A., Jain, P., Bergthold, G., Wala, J., Zeid, R., et al. (2016). MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nature Genetics, 48, 273\u2013282. https:\/\/doi.org\/10.1038\/ng.3500","journal-title":"Nature Genetics"},{"key":"10153_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jnen\/nlac123","volume":"82","author":"YY Suh","year":"2023","unstructured":"Suh, Y. Y., Lee, K., Shim, Y. M., Phi, J. H., Park, C. K., Kim, S. K., et al. (2023). MYB\/MYBL1::QKI fusion-positive diffuse glioma. Journal of Neuropathology and Experimental Neurology, 82, 250\u2013260. https:\/\/doi.org\/10.1093\/jnen\/nlac123","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10153_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/path.5006","volume":"244","author":"J Kim","year":"2018","unstructured":"Kim, J., Geyer, F. C., Martelotto, L. G., Ng, C. K., Lim, R. S., Selenica, P., et al. (2018). MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene. The Journal of Pathology, 244, 143\u2013150. https:\/\/doi.org\/10.1002\/path.5006","journal-title":"The Journal of Pathology"},{"key":"10153_CR47","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1158\/1078-0432.CCR-15-2867-T","volume":"22","author":"Y Mitani","year":"2016","unstructured":"Mitani, Y., Liu, B., Rao, P. H., Borra, V. J., Zafereo, M., Weber, R. S., et al. (2016). Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB Fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations. Clinical Cancer Research, 22, 725\u2013733. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2867-T","journal-title":"Clinical Cancer Research"},{"key":"10153_CR48","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144, 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"10153_CR49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/978-3-642-74006-0_42","volume":"141","author":"WM Kuehl","year":"1988","unstructured":"Kuehl, W. M., Bender, T. P., Stafford, J., McClinton, D., Segal, S., & Dmitrovsky, E. (1988). Expression and function of the c-myb oncogene during hematopoietic differentiation. Current Topics in Microbiology and Immunology, 141, 318\u2013323. https:\/\/doi.org\/10.1007\/978-3-642-74006-0_42","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"10153_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1432-0436.1989.tb00603.x","volume":"42","author":"PJ Dyson","year":"1989","unstructured":"Dyson, P. J., Poirier, F., & Watson, R. J. (1989). Expression of c-myb in embryonal carcinoma cells and embryonal stem cells. Differentiation, 42, 24\u201327. https:\/\/doi.org\/10.1111\/j.1432-0436.1989.tb00603.x","journal-title":"Differentiation"},{"key":"10153_CR51","first-page":"113","volume":"5","author":"M Introna","year":"1994","unstructured":"Introna, M., Luchetti, M., Castellano, M., Arsura, M., & Golay, J. (1994). The myb oncogene family of transcription factors: Potent regulators of hematopoietic cell proliferation and differentiation. Seminars in Cancer Biology, 5, 113\u2013124.","journal-title":"Seminars in Cancer Biology"},{"key":"10153_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang, Y., Hong, W., & Wei, X. (2022). The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. Journal of Hematology & Oncology, 15, 129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8","journal-title":"Journal of Hematology & Oncology"},{"key":"10153_CR53","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1007\/s00018-005-5297-7","volume":"62","author":"V Karafiat","year":"2005","unstructured":"Karafiat, V., Dvorakova, M., Krejci, E., Kralova, J., Pajer, P., Snajdr, P., et al. (2005). Transcription factor c-Myb is involved in the regulation of the epithelial-mesenchymal transition in the avian neural crest. Cellular and Molecular Life Sciences, 62, 2516\u20132525. https:\/\/doi.org\/10.1007\/s00018-005-5297-7","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10153_CR54","doi-asserted-by":"publisher","first-page":"29434","DOI":"10.1074\/jbc.M109.089045","volume":"285","author":"B Tanno","year":"2010","unstructured":"Tanno, B., Sesti, F., Cesi, V., Bossi, G., Ferrari-Amorotti, G., Bussolari, R., et al. (2010). Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin. Journal of Biological Chemistry, 285, 29434\u201329445. https:\/\/doi.org\/10.1074\/jbc.M109.089045","journal-title":"Journal of Biological Chemistry"},{"key":"10153_CR55","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.4161\/cc.10.23.18346","volume":"10","author":"V Cesi","year":"2011","unstructured":"Cesi, V., Casciati, A., Sesti, F., Tanno, B., Calabretta, B., & Raschella, G. (2011). TGFbeta-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. Cell Cycle, 10, 4149\u20134161. https:\/\/doi.org\/10.4161\/cc.10.23.18346","journal-title":"Cell Cycle"},{"key":"10153_CR56","doi-asserted-by":"publisher","first-page":"1081333","DOI":"10.3389\/fonc.2023.1081333","volume":"13","author":"J Cheng","year":"2023","unstructured":"Cheng, J., Wu, K., Yang, Q., Zhu, Z., & Zhao, H. (2023). RNF6 activates TGF-beta1\/c-Myb pathway to promote EMT in esophageal squamous cell carcinoma. Frontiers in Oncology, 13, 1081333. https:\/\/doi.org\/10.3389\/fonc.2023.1081333","journal-title":"Frontiers in Oncology"},{"key":"10153_CR57","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/carcin\/bgs134","volume":"33","author":"SK Srivastava","year":"2012","unstructured":"Srivastava, S. K., Bhardwaj, A., Singh, S., Arora, S., McClellan, S., Grizzle, W. E., et al. (2012). Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: Potential role in castration resistance. Carcinogenesis, 33, 1149\u20131157. https:\/\/doi.org\/10.1093\/carcin\/bgs134","journal-title":"Carcinogenesis"},{"key":"10153_CR58","doi-asserted-by":"publisher","first-page":"e55643","DOI":"10.15252\/embr.202255643","volume":"24","author":"S Anand","year":"2023","unstructured":"Anand, S., Khan, M. A., Zubair, H., Sudan, S. K., Vikramdeo, K. S., Deshmukh, S. K., et al. (2023). MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. EMBO Reports, 24, e55643. https:\/\/doi.org\/10.15252\/embr.202255643","journal-title":"EMBO Reports"},{"key":"10153_CR59","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.1038\/s41598-017-07126-7","volume":"7","author":"D Kim","year":"2017","unstructured":"Kim, D., You, E., Jeong, J., Ko, P., Kim, J. W., & Rhee, S. (2017). DDR2 controls the epithelial-mesenchymal-transition-related gene expression via c-Myb acetylation upon matrix stiffening. Scientific Reports, 7, 6847. https:\/\/doi.org\/10.1038\/s41598-017-07126-7","journal-title":"Scientific Reports"},{"key":"10153_CR60","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1111\/cas.14141","volume":"110","author":"X Qu","year":"2019","unstructured":"Qu, X., Yan, X., Kong, C., Zhu, Y., Li, H., Pan, D., et al. (2019). c-Myb promotes growth and metastasis of colorectal cancer through c-fos-induced epithelial-mesenchymal transition. Cancer Science, 110, 3183\u20133196. https:\/\/doi.org\/10.1111\/cas.14141","journal-title":"Cancer Science"},{"key":"10153_CR61","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3892\/ijo.2019.4754","volume":"54","author":"LH Xu","year":"2019","unstructured":"Xu, L. H., Zhao, F., Yang, W. W., Chen, C. W., Du, Z. H., Fu, M., et al. (2019). MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma. International Journal of Oncology, 54, 1579\u20131590. https:\/\/doi.org\/10.3892\/ijo.2019.4754","journal-title":"International Journal of Oncology"},{"key":"10153_CR62","first-page":"1960","volume":"12","author":"M Wei","year":"2022","unstructured":"Wei, M., Yang, R., Ye, M., Zhan, Y., Liu, B., Meng, L., et al. (2022). MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad\/SNAI1 pathway. American Journal of Cancer Research, 12, 1960\u20131981.","journal-title":"American Journal of Cancer Research"},{"key":"10153_CR63","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12032-014-0412-y","volume":"32","author":"D Tao","year":"2015","unstructured":"Tao, D., Pan, Y., Jiang, G., Lu, H., Zheng, S., Lin, H., et al. (2015). B-Myb regulates snail expression to promote epithelial-to-mesenchymal transition and invasion of breast cancer cell. Medical Oncology, 32, 412. https:\/\/doi.org\/10.1007\/s12032-014-0412-y","journal-title":"Medical Oncology"},{"key":"10153_CR64","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/1873-3468.14085","volume":"595","author":"G Fiscon","year":"2021","unstructured":"Fiscon, G., Pegoraro, S., Conte, F., Manfioletti, G., & Paci, P. (2021). Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes HMGA1, FOXM1, and MYBL2 in triple-negative breast cancer. FEBS Letters, 595, 1569\u20131586. https:\/\/doi.org\/10.1002\/1873-3468.14085","journal-title":"FEBS Letters"},{"key":"10153_CR65","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.omto.2020.05.016","volume":"18","author":"B Xie","year":"2020","unstructured":"Xie, B., Liu, Y., Zhao, Z., Liu, Q., Wang, X., Xie, Y., et al. (2020). MYB proto-oncogene-like 1-TWIST1 axis promotes growth and metastasis of hepatocellular carcinoma cells. Molecular Therapy Oncolytics, 18, 58\u201369. https:\/\/doi.org\/10.1016\/j.omto.2020.05.016","journal-title":"Molecular Therapy Oncolytics"},{"key":"10153_CR66","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/319374a0","volume":"319","author":"CB Thompson","year":"1986","unstructured":"Thompson, C. B., Challoner, P. B., Neiman, P. E., & Groudine, M. (1986). Expression of the c-myb proto-oncogene during cellular proliferation. Nature, 319, 374\u201380. https:\/\/doi.org\/10.1038\/319374a0","journal-title":"Nature"},{"key":"10153_CR67","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1073\/pnas.86.9.3379","volume":"86","author":"G Anfossi","year":"1989","unstructured":"Anfossi, G., Gewirtz, A. M., & Calabretta, B. (1989). An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proceedings of the Nationsl Academy of Sciences U S A, 86, 3379\u20133383. https:\/\/doi.org\/10.1073\/pnas.86.9.3379","journal-title":"Proceedings of the Nationsl Academy of Sciences U S A"},{"key":"10153_CR68","doi-asserted-by":"publisher","first-page":"13762","DOI":"10.1073\/pnas.0700104104","volume":"104","author":"Y Drabsch","year":"2007","unstructured":"Drabsch, Y., Hugo, H., Zhang, R., Dowhan, D. H., Miao, Y. R., Gewirtz, A. M., et al. (2007). Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proceedings of the National Academy Sciences U S A, 104, 13762\u201313767. https:\/\/doi.org\/10.1073\/pnas.0700104104","journal-title":"Proceedings of the National Academy Sciences U S A"},{"key":"10153_CR69","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1158\/0008-5472.CAN-11-1015","volume":"71","author":"RY Miao","year":"2011","unstructured":"Miao, R. Y., Drabsch, Y., Cross, R. S., Cheasley, D., Carpinteri, S., Pereira, L., et al. (2011). MYB is essential for mammary tumorigenesis. Cancer Research, 71, 7029\u20137037. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1015","journal-title":"Cancer Research"},{"key":"10153_CR70","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.leukres.2013.01.012","volume":"37","author":"P Ye","year":"2013","unstructured":"Ye, P., Zhao, L., & Gonda, T. J. (2013). The MYB oncogene can suppress apoptosis in acute myeloid leukemia cells by transcriptional repression of DRAK2 expression. Leukemia Research, 37, 595\u2013601. https:\/\/doi.org\/10.1016\/j.leukres.2013.01.012","journal-title":"Leukemia Research"},{"key":"10153_CR71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2407-11-30","volume":"11","author":"AM Quintana","year":"2011","unstructured":"Quintana, A. M., Liu, F., O\u2019Rourke, J. P., & Ness, S. A. (2011). Identification and regulation of c-Myb target genes in MCF-7 cells. BMC Cancer, 11, 30. https:\/\/doi.org\/10.1186\/1471-2407-11-30","journal-title":"BMC Cancer"},{"key":"10153_CR72","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/bjc.2015.400","volume":"113","author":"SK Srivastava","year":"2015","unstructured":"Srivastava, S. K., Bhardwaj, A., Arora, S., Singh, S., Azim, S., Tyagi, N., et al. (2015). MYB is a novel regulator of pancreatic tumour growth and metastasis. British Journal of Cancer, 113, 1694\u20131703. https:\/\/doi.org\/10.1038\/bjc.2015.400","journal-title":"British Journal of Cancer"},{"key":"10153_CR73","doi-asserted-by":"publisher","first-page":"28446","DOI":"10.1038\/srep28446","volume":"6","author":"S Azim","year":"2016","unstructured":"Azim, S., Zubair, H., Srivastava, S. K., Bhardwaj, A., Zubair, A., Ahmad, A., et al. (2016). Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer. Scientific Reports, 6, 28446. https:\/\/doi.org\/10.1038\/srep28446","journal-title":"Scientific Reports"},{"key":"10153_CR74","doi-asserted-by":"publisher","first-page":"102725","DOI":"10.1016\/j.jbc.2022.102725","volume":"299","author":"S Acharya","year":"2023","unstructured":"Acharya, S., Anand, S., Khan, M. A., Zubair, H., Srivastava, S. K., Singh, S., et al. (2023). Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer. Journal of Biological Chemistry, 299, 102725. https:\/\/doi.org\/10.1016\/j.jbc.2022.102725","journal-title":"Journal of Biological Chemistry"},{"key":"10153_CR75","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1615\/critrevoncog.v5.i4.30","volume":"5","author":"J Lyon","year":"1994","unstructured":"Lyon, J., Robinson, C., & Watson, R. (1994). The role of Myb proteins in normal and neoplastic cell proliferation. Critical Reviews in Oncogenesis, 5, 373\u2013388. https:\/\/doi.org\/10.1615\/critrevoncog.v5.i4.30","journal-title":"Critical Reviews in Oncogenesis"},{"key":"10153_CR76","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1038\/s41388-022-02456-x","volume":"41","author":"W Liu","year":"2022","unstructured":"Liu, W., Shen, D., Ju, L., Zhang, R., Du, W., Jin, W., et al. (2022). MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3. Oncogene, 41, 4606\u20134617. https:\/\/doi.org\/10.1038\/s41388-022-02456-x","journal-title":"Oncogene"},{"key":"10153_CR77","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1038\/s41388-019-0801-y","volume":"38","author":"T Wei","year":"2019","unstructured":"Wei, T., Weiler, S. M. E., Toth, M., Sticht, C., Lutz, T., Thomann, S., et al. (2019). YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cells. Oncogene, 38, 5541\u20135550. https:\/\/doi.org\/10.1038\/s41388-019-0801-y","journal-title":"Oncogene"},{"key":"10153_CR78","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11010-020-03721-x","volume":"468","author":"YC Xiong","year":"2020","unstructured":"Xiong, Y. C., Wang, J., Cheng, Y., Zhang, X. Y., & Ye, X. Q. (2020). Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH. Molecular and Cellular Biochemistry, 468, 185\u2013193. https:\/\/doi.org\/10.1007\/s11010-020-03721-x","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10153_CR79","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mc.20147","volume":"45","author":"N Hanada","year":"2006","unstructured":"Hanada, N., Lo, H. W., Day, C. P., Pan, Y., Nakajima, Y., & Hung, M. C. (2006). Co-regulation of B-Myb expression by E2F1 and EGF receptor. Molecular Carcinogenesis, 45, 10\u201317. https:\/\/doi.org\/10.1002\/mc.20147","journal-title":"Molecular Carcinogenesis"},{"key":"10153_CR80","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1182\/blood.V79.10.2708.2708","volume":"79","author":"M Arsura","year":"1992","unstructured":"Arsura, M., Introna, M., Passerini, F., Mantovani, A., & Golay, J. (1992). B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. Blood, 79, 2708\u20132716. https:\/\/doi.org\/10.1182\/blood.V79.10.2708.2708","journal-title":"Blood"},{"key":"10153_CR81","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.4049\/jimmunol.160.6.2786","volume":"160","author":"J Golay","year":"1998","unstructured":"Golay, J., Broccoli, V., Lamorte, G., Bifulco, C., Parravicini, C., Pizzey, A., et al. (1998). The A-Myb transcription factor is a marker of centroblasts in vivo. The Journal of Immunology, 160, 2786\u20132793. https:\/\/doi.org\/10.4049\/jimmunol.160.6.2786","journal-title":"The Journal of Immunology"},{"key":"10153_CR82","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-15-2302","volume":"76","author":"Y Li","year":"2016","unstructured":"Li, Y., Jin, K., van Pelt, G. W., van Dam, H., Yu, X., Mesker, W. E., et al. (2016). c-Myb enhances breast cancer invasion and metastasis through the Wnt\/beta-catenin\/axin2 pathway. Cancer Research, 76, 3364\u20133375. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2302","journal-title":"Cancer Research"},{"key":"10153_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-4598-11-15","volume":"11","author":"L Knopfova","year":"2012","unstructured":"Knopfova, L., Benes, P., Pekarcikova, L., Hermanova, M., Masarik, M., Pernicova, Z., et al. (2012). \u201dc-Myb regulates matrix metalloproteinases 1\/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis\u201d. Molecular Cancer, 11, 15. https:\/\/doi.org\/10.1186\/1476-4598-11-15","journal-title":"Molecular Cancer"},{"key":"10153_CR84","doi-asserted-by":"publisher","first-page":"10723","DOI":"10.1007\/s13277-016-4956-7","volume":"37","author":"M Tichy","year":"2016","unstructured":"Tichy, M., Knopfova, L., Jarkovsky, J., Pekarcikova, L., Veverkova, L., Vlcek, P., et al. (2016). Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma. Tumour Biology, 37, 10723\u201310729. https:\/\/doi.org\/10.1007\/s13277-016-4956-7","journal-title":"Tumour Biology"},{"key":"10153_CR85","doi-asserted-by":"publisher","unstructured":"Y. Jin, H. Zhu, W. Cai, X. Fan, Y. Wang, Y. Niu, et al. (2017). \"B-Myb is up-regulated and promotes cell growth and motility in non-small cell lung cancer,\" Int J Mol Sci, 18 https:\/\/doi.org\/10.3390\/ijms18060860","DOI":"10.3390\/ijms18060860"},{"key":"10153_CR86","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41419-022-05180-2","volume":"13","author":"J Zhu","year":"2022","unstructured":"Zhu, J., Wu, Y., Yu, Y., Li, Y., Shen, J., & Zhang, R. (2022). MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma. Cell Death Disease, 13, 727. https:\/\/doi.org\/10.1038\/s41419-022-05180-2","journal-title":"Cell Death Disease"},{"key":"10153_CR87","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"B Mansoori","year":"2017","unstructured":"Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017). The different mechanisms of cancer drug resistance: a brief review. Advanced Pharmaceutical Bulletin, 7, 339\u2013348. https:\/\/doi.org\/10.15171\/apb.2017.041","journal-title":"Advanced Pharmaceutical Bulletin"},{"key":"10153_CR88","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3892\/or.8.4.807","volume":"8","author":"T Funato","year":"2001","unstructured":"Funato, T., Satou, J., Kozawa, K., Fujimaki, S., Miura, T., & Kaku, M. (2001). Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin. Oncology Reports, 8, 807\u201310. https:\/\/doi.org\/10.3892\/or.8.4.807","journal-title":"Oncology Reports"},{"key":"10153_CR89","doi-asserted-by":"publisher","first-page":"21126","DOI":"10.1002\/jcp.28715","volume":"234","author":"M Tian","year":"2019","unstructured":"Tian, M., Tian, D., Qiao, X., Li, J., & Zhang, L. (2019). Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors. Journal of Cellular Physiology, 234, 21126\u201321134. https:\/\/doi.org\/10.1002\/jcp.28715","journal-title":"Journal of Cellular Physiology"},{"key":"10153_CR90","doi-asserted-by":"publisher","first-page":"18844","DOI":"10.1038\/s41598-019-54289-6","volume":"9","author":"Y Gao","year":"2019","unstructured":"Gao, Y., Zhang, W., Liu, C., & Li, G. (2019). miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB. Scientific Reports, 9, 18844. https:\/\/doi.org\/10.1038\/s41598-019-54289-6","journal-title":"Scientific Reports"},{"key":"10153_CR91","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1038\/s41388-019-0789-3","volume":"38","author":"RM Yang","year":"2019","unstructured":"Yang, R. M., Nanayakkara, D., Kalimutho, M., Mitra, P., Khanna, K. K., Dray, E., et al. (2019). MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells. Oncogene, 38, 5239\u20135249. https:\/\/doi.org\/10.1038\/s41388-019-0789-3","journal-title":"Oncogene"},{"key":"10153_CR92","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.febslet.2015.01.012","volume":"589","author":"W Wang","year":"2015","unstructured":"Wang, W., Wu, S., Shi, Y., Miao, Y., Luo, X., Ji, M., et al. (2015). c-MYB regulates cell growth and DNA damage repair through modulating MiR-143. FEBS Letters, 589, 555\u2013564. https:\/\/doi.org\/10.1016\/j.febslet.2015.01.012","journal-title":"FEBS Letters"},{"key":"10153_CR93","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.cellsig.2016.04.007","volume":"28","author":"L Pekarcikova","year":"2016","unstructured":"Pekarcikova, L., Knopfova, L., Benes, P., & Smarda, J. (2016). c-Myb regulates NOX1\/p38 to control survival of colorectal carcinoma cells. Cellular Signalling, 28, 924\u2013936. https:\/\/doi.org\/10.1016\/j.cellsig.2016.04.007","journal-title":"Cellular Signalling"},{"key":"10153_CR94","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/emmm.201302827","volume":"5","author":"FA Siebzehnrubl","year":"2013","unstructured":"Siebzehnrubl, F. A., Silver, D. J., Tugertimur, B., Deleyrolle, L. P., Siebzehnrubl, D., Sarkisian, M. R., et al. (2013). The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Molecular Medicine, 5, 1196\u20131212. https:\/\/doi.org\/10.1002\/emmm.201302827","journal-title":"EMBO Molecular Medicine"},{"key":"10153_CR95","doi-asserted-by":"publisher","unstructured":"P. Posdzich, C. Darr, T. Hilser, M. Wahl, K. Herrmann, B. Hadaschik, et al. (2023). \"Metastatic Prostate cancer-a review of current treatment options and promising new approaches.\" Cancers (Basel), 15 https:\/\/doi.org\/10.3390\/cancers15020461.","DOI":"10.3390\/cancers15020461"},{"key":"10153_CR96","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3978\/j.issn.2223-4683.2015.05.02","volume":"4","author":"T Chandrasekar","year":"2015","unstructured":"Chandrasekar, T., Yang, J. C., Gao, A. C., & Evans, C. P. (2015). Mechanisms of resistance in castration-resistant prostate cancer (CRPC). Translational Andrology Urology, 4, 365\u2013380. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2015.05.02","journal-title":"Translational Andrology Urology"},{"key":"10153_CR97","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41416-021-01641-1","volume":"126","author":"SK Srivastava","year":"2022","unstructured":"Srivastava, S. K., Khan, M. A., Anand, S., Zubair, H., Deshmukh, S. K., Patel, G. K., et al. (2022). MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer. British Journal of Cancer, 126, 1205\u20131214. https:\/\/doi.org\/10.1038\/s41416-021-01641-1","journal-title":"British Journal of Cancer"},{"key":"10153_CR98","doi-asserted-by":"publisher","first-page":"12901","DOI":"10.1038\/s41598-021-92352-3","volume":"11","author":"O Miree","year":"2021","unstructured":"Miree, O., Srivastava, S. K., Khan, M. A., Sameeta, F., Acharya, S., Ndetan, H., et al. (2021). Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancer. Scientific Reports, 11, 12901. https:\/\/doi.org\/10.1038\/s41598-021-92352-3","journal-title":"Scientific Reports"},{"key":"10153_CR99","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1002\/1878-0261.13314","volume":"16","author":"Y Yoshikawa","year":"2022","unstructured":"Yoshikawa, Y., Stopsack, K. H., Wang, X. V., Chen, Y. H., Mazzu, Y. Z., Burton, F., et al. (2022). Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer. Molecular Oncology, 16, 3994\u20134010. https:\/\/doi.org\/10.1002\/1878-0261.13314","journal-title":"Molecular Oncology"},{"key":"10153_CR100","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.7150\/thno.56604","volume":"11","author":"Q Li","year":"2021","unstructured":"Li, Q., Wang, M., Hu, Y., Zhao, E., Li, J., Ren, L., et al. (2021). MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer. Theranostics, 11, 5794\u20135812. https:\/\/doi.org\/10.7150\/thno.56604","journal-title":"Theranostics"},{"key":"10153_CR101","first-page":"2451","volume":"59","author":"E Grassilli","year":"1999","unstructured":"Grassilli, E., Salomoni, P., Perrotti, D., Franceschi, C., & Calabretta, B. (1999). Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction. Cancer Research, 59, 2451\u20132456.","journal-title":"Cancer Research"},{"key":"10153_CR102","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-230X(09)05007-6","volume":"105","author":"A Sala","year":"2009","unstructured":"Sala, A., Bettuzzi, S., Pucci, S., Chayka, O., Dews, M., & Thomas-Tikhonenko, A. (2009). Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis. Advances in Cancer Research, 105, 115\u2013132. https:\/\/doi.org\/10.1016\/S0065-230X(09)05007-6","journal-title":"Advances in Cancer Research"},{"key":"10153_CR103","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10735-020-09920-6","volume":"52","author":"X Li","year":"2021","unstructured":"Li, X., Zhang, X., Wu, C. C., Li, P. P., Fu, Y. M., Xie, L. H., et al. (2021). The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer. Journal of Molecular Histology, 52, 21\u201330. https:\/\/doi.org\/10.1007\/s10735-020-09920-6","journal-title":"Journal of Molecular Histology"},{"key":"10153_CR104","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1080\/15384101.2021.1982494","volume":"20","author":"X Chen","year":"2021","unstructured":"Chen, X., Lu, Y., Yu, H., Du, K., Zhang, Y., Nan, Y., et al. (2021). Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogene. Cell Cycle, 20, 2291\u20132308. https:\/\/doi.org\/10.1080\/15384101.2021.1982494","journal-title":"Cell Cycle"},{"key":"10153_CR105","doi-asserted-by":"publisher","first-page":"585551","DOI":"10.3389\/fonc.2020.585551","volume":"10","author":"BB Morris","year":"2020","unstructured":"Morris, B. B., Wages, N. A., Grant, P. A., Stukenberg, P. T., Gentzler, R. D., Hall, R. D., et al. (2020). MYBL2-driven transcriptional programs link replication stress and error-prone DNA repair with genomic instability in lung adenocarcinoma. Frontiers in Oncology, 10, 585551. https:\/\/doi.org\/10.3389\/fonc.2020.585551","journal-title":"Frontiers in Oncology"},{"key":"10153_CR106","first-page":"389","volume":"11","author":"G Qi","year":"2021","unstructured":"Qi, G., Zhang, C., Ma, H., Li, Y., Peng, J., Chen, J., et al. (2021). CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer. American Journal of Cancer Research, 11, 389\u2013415.","journal-title":"American Journal of Cancer Research"},{"key":"10153_CR107","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-016-0740-2","volume":"18","author":"KM Bussard","year":"2016","unstructured":"Bussard, K. M., Mutkus, L., Stumpf, K., Gomez-Manzano, C., & Marini, F. C. (2016). Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Research, 18, 84. https:\/\/doi.org\/10.1186\/s13058-016-0740-2","journal-title":"Breast Cancer Research"},{"key":"10153_CR108","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10555-008-9175-2","volume":"28","author":"M Sund","year":"2009","unstructured":"Sund, M., & Kalluri, R. (2009). Tumor stroma derived biomarkers in cancer. Cancer and Metastasis Reviews, 28, 177\u2013183. https:\/\/doi.org\/10.1007\/s10555-008-9175-2","journal-title":"Cancer and Metastasis Reviews"},{"key":"10153_CR109","doi-asserted-by":"publisher","first-page":"16263","DOI":"10.1074\/jbc.M116.732651","volume":"291","author":"A Bhardwaj","year":"2016","unstructured":"Bhardwaj, A., Srivastava, S. K., Singh, S., Tyagi, N., Arora, S., Carter, J. E., et al. (2016). MYB promotes desmoplasia in pancreatic cancer through direct transcriptional up-regulation and cooperative action of sonic hedgehog and adrenomedullin. Journal of Biological Chemistry, 291, 16263\u201316270. https:\/\/doi.org\/10.1074\/jbc.M116.732651","journal-title":"Journal of Biological Chemistry"},{"key":"10153_CR110","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.1171362","volume":"324","author":"KP Olive","year":"2009","unstructured":"Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., et al. (2009). Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science, 324, 1457\u20131461. https:\/\/doi.org\/10.1126\/science.1171362","journal-title":"Science"},{"key":"10153_CR111","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2020.07.041","volume":"492","author":"VM Shah","year":"2020","unstructured":"Shah, V. M., Sheppard, B. C., Sears, R. C., & Alani, A. W. (2020). Hypoxia: Friend or foe for drug delivery in pancreatic cancer. Cancer Letters, 492, 63\u201370. https:\/\/doi.org\/10.1016\/j.canlet.2020.07.041","journal-title":"Cancer Letters"},{"key":"10153_CR112","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/HP.S52636","volume":"2","author":"A Yuen","year":"2014","unstructured":"Yuen, A., & Diaz, B. (2014). The impact of hypoxia in pancreatic cancer invasion and metastasis. Hypoxia (Auckl), 2, 91\u2013106. https:\/\/doi.org\/10.2147\/HP.S52636","journal-title":"Hypoxia (Auckl)"},{"key":"10153_CR113","doi-asserted-by":"publisher","first-page":"e1149667","DOI":"10.1080\/2162402X.2016.1149667","volume":"5","author":"R Millen","year":"2016","unstructured":"Millen, R., Malaterre, J., Cross, R. S., Carpinteri, S., Desai, J., Tran, B., et al. (2016). Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer. Oncoimmunology, 5, e1149667. https:\/\/doi.org\/10.1080\/2162402X.2016.1149667","journal-title":"Oncoimmunology"},{"key":"10153_CR114","doi-asserted-by":"publisher","first-page":"e26788","DOI":"10.4161\/onci.26788","volume":"2","author":"J Watt","year":"2013","unstructured":"Watt, J., & Kocher, H. M. (2013). The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration. Oncoimmunology, 2, e26788. https:\/\/doi.org\/10.4161\/onci.26788","journal-title":"Oncoimmunology"},{"key":"10153_CR115","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","volume":"14","author":"Z Xiao","year":"2023","unstructured":"Xiao, Z., Todd, L., Huang, L., Noguera-Ortega, E., Lu, Z., Huang, L., et al. (2023). Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors. Nature Communications, 14, 5110. https:\/\/doi.org\/10.1038\/s41467-023-40850-5","journal-title":"Nature Communications"},{"key":"10153_CR116","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1073\/pnas.1815515116","volume":"116","author":"IX Chen","year":"2019","unstructured":"Chen, I. X., Chauhan, V. P., Posada, J., Ng, M. R., Wu, M. W., Adstamongkonkul, P., et al. (2019). Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer. Proceeding of the National Academy Sciences U S A, 116, 4558\u20134566. https:\/\/doi.org\/10.1073\/pnas.1815515116","journal-title":"Proceeding of the National Academy Sciences U S A"},{"key":"10153_CR117","doi-asserted-by":"publisher","first-page":"28960","DOI":"10.1073\/pnas.2013644117","volume":"117","author":"D Biasci","year":"2020","unstructured":"Biasci, D., Smoragiewicz, M., Connell, C. M., Wang, Z., Gao, Y., Thaventhiran, J. E. D., et al. (2020). CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proceedings of the National Academy Sciences U S A, 117, 28960\u201328970. https:\/\/doi.org\/10.1073\/pnas.2013644117","journal-title":"Proceedings of the National Academy Sciences U S A"},{"key":"10153_CR118","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe, J. P., Desprez, P. Y., Krtolica, A., & Campisi, J. (2010). The senescence-associated secretory phenotype: The dark side of tumor suppression. Annual Review of Pathology: Mechanisms of Disease, 5, 99\u2013118. https:\/\/doi.org\/10.1146\/annurev-pathol-121808-102144","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"10153_CR119","doi-asserted-by":"publisher","first-page":"21","DOI":"10.18632\/oncotarget.22940","volume":"9","author":"KC Flanagan","year":"2018","unstructured":"Flanagan, K. C., Alspach, E., Pazolli, E., Parajuli, S., Ren, Q., Arthur, L. L., et al. (2018). c-Myb and C\/EBPbeta regulate OPN and other senescence-associated secretory phenotype factors. Oncotarget, 9, 21\u201336. https:\/\/doi.org\/10.18632\/oncotarget.22940","journal-title":"Oncotarget"},{"key":"10153_CR120","doi-asserted-by":"publisher","first-page":"20741","DOI":"10.18632\/oncotarget.15119","volume":"8","author":"X Wu","year":"2017","unstructured":"Wu, X., Tao, P., Zhou, Q., Li, J., Yu, Z., Wang, X., et al. (2017). IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2\/STAT3 signaling pathway. Oncotarget, 8, 20741\u201320750. https:\/\/doi.org\/10.18632\/oncotarget.15119","journal-title":"Oncotarget"},{"key":"10153_CR121","doi-asserted-by":"publisher","unstructured":"K. Jin, N. B. Pandey, and A. S. Popel 2017 \"Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis.\" Oncotarget 8, 60210\u201360222 https:\/\/doi.org\/10.18632\/oncotarget.19417","DOI":"10.18632\/oncotarget.19417"},{"key":"10153_CR122","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4049\/jimmunol.1700609","volume":"200","author":"J Ringleb","year":"2018","unstructured":"Ringleb, J., Strack, E., Angioni, C., Geisslinger, G., Steinhilber, D., Weigert, A., et al. (2018). Apoptotic cancer cells suppress 5-lipoxygenase in tumor-associated macrophages. The Journal of Immunology, 200, 857\u2013868. https:\/\/doi.org\/10.4049\/jimmunol.1700609","journal-title":"The Journal of Immunology"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-023-10153-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-023-10153-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-023-10153-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T08:09:11Z","timestamp":1712995751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-023-10153-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10153"],"URL":"https:\/\/doi.org\/10.1007\/s10555-023-10153-8","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare \u2018no conflict of interest\u2019.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}